Platform Computing drives scientific breakthroughs. Platform Computing, which was acquired by IBM, announced that Cancer Research UK, a world leader in the study of cancer, has turned to Platform LSF to help drive forward its human genome research project at the Cambridge Research Institute (CRI). The institute has gained greater insight into genetic cancer mutations through an advanced genetic sequencing platform that was paired with Platform LSF. CRI has already saved the equivalent in man hours of one full-time employee by integrating Platform LSF. ”Platform LSF gives us the means to produce and manage a wealth of gene sequencing data that we could only have dreamed about previously,” said Peter Maccallum, head of IT and scientific computing at Cancer Research UK in Cambridge. “This has already lead to tangible published work looking into breast cancer, and is proving its worth in helping our researchers further the understanding of how cancers progress.”

Read More